Evaluation of venous thromboembolism prophylaxis in a high complexity hospital;Avaliação da profilaxia do tromboembolismo venoso em hospital de grande porte

Revista do Colegio Brasileiro de Cirurgioes

Volumn 37, Issue 3, 2010, Pages 204-210

  Carneiro, João Luiz de Aquino ^a   Targueta, Gabriel Pelegrineti ^b   Marino, Lucas Oliveira ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Heparin; Prophylaxis; Risk factors; Venous thromboembolism

Indexed keywords

EID: 77956949415     PISSN: 01006991     EISSN: 18094546     Source Type: Journal    
DOI: 10.1590/s0100-69912010000300008     Document Type: Article

References (27)

1. Francis CW. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med. 2007; 356(14): 1438-44.
2. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008; 133(6. Suppl): 381S-453S.
3. National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. NICE clinical guideline No. 46:1-160. Available from: http://www.nice.org.uk/ CG046
4. Leite TL, Melo CFL, Calheiros GA, Silva MDC, Pitta GBB. Avaliação da utilização de profilaxia da trombose venosa profunda em um hospital escola. J Vasc Bras. 2007; 6(4): 344-351.
5. Ribeiro MA, Netto PG, Lage SG. Desafios na profilaxia do tromboembolismo venoso: abordagem do paciente crítico. Rev Bras Ter Intensiva 2006: 18(3): 316-9.
6. Franco RM, Simezo V, Bortoleti RR, Braga EL, Abrão AR, Linardi F, Costa JA. Profilaxia para tromboembolismo venoso em um hospital de ensino. J Vasc Bras. 2006: 5(2): 131-8.
7. Caiafa JS, Bastos M. Programa de profilaxia do tromboembolismo venoso do Hospital Naval Marcílio Dias: um modelo de educação continuada. J Vasc Bras. 2002; 1(2): 103-12.
8. Geerts WH, Heit JA, Claggett GP, Pineo GF, Colwell CW, Anderson FA et al. Prevention of deep venous thromboembolism. Chest. 2001; 119 Suppl 1: 132S-75S.
9. Kakkar AK, Davidson BL, Haas SK; The Investigators Against Thromboembolism (INATE) Core Group. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2004; 2(2): 221-7.
10. Sullivan SD, Kahn SR, Davidson BL, Borris L, Bossuyt P, Raskob G. Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Pharmacoeconomics. 2003; 21(7):477-96.
11. Caprini JA, Botteman MF, Stephens JM, Nadipelli V, Ewing MM, Brandt S et al. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health. 2003; 6(1): 59-74.
12. Avorn J, Winkelmayer WC. Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism. Circulation. 2004; 110 (24 Suppl 1):IV25-32.
13. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ. 2006; 332(7537): 325-9. Epub 2006 Jan 26.
14. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999; 341(11): 793-800.
15. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004; 110(7): 874-9. Epub 2004 Aug 2.
16. Ellis MH, Elis A. Perioperative venous thromboembolism prophylaxis in Israel: a survey of academic surgical departments. Eur J Haematol 2004; 73(2): 104-8.
17. National Institute of Clinical Studies. The prevalence of chemoprophylaxis in surgical and medical cases at high risk of venous thromboembolism. Melbourne, Australia: School of Population Health, University of Western Australia, 2005; 1-27.
18. Rashid ST, Thursz MR, Razvi NA, Voller R, Orchard T, Rashid ST, Shlebak AA. Venous thromboprophylaxis in UK medical inpatients. J R Soc Med. 2005; 98(11): 507-12.
19. Deheinzelin D, Braga AL, Martins LC, Martins MA, Hernandez A, Yoshida WB, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost. 2006; 4(6): 1266-70.
20. Goldhaber SZ, Tapson VF; DVT FREE Steering Commitee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004; 93(2): 259-62.
21. Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 1997; 16(1): 3-38.
22. Bergmann JF, Neuhart E. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost. 1996; 76(4): 529-34.
23. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005; 106(8): 2710-5. Epub 2005 Jun 28.
24. Bergqvist D, Lindgren B, Mätzsch T. Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin. Br J Surg. 1996; 83(11):1548-52.
25. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thomboembolism. Ann Intern Med. 1991; 115(8): 591-5.
26. Engelhorn ALV, Garcia ACF, Cassou AF, Birckholz L, Engelhorn CA. Profilaxia da trombose venosa profunda: estudo epidemiológico em um hospital escola. J Vasc Bras. 2002; 1(2): 97-102.
27. Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates. Am J Hematol. 2005; 78(3): 167-72.